Otonomy, Inc

Otonomy, Inc

Otonomy, Inc

Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Founded
2008
Raised
$143.4M
Follow us
Alexa global traffic share
Latest funding Show all
$49,000,000
Venture capital (Series D) - 2014
$45,900,000
Venture capital (Series C) - 2013
Team Size
50+
Employees
Xconomy

Otonomy Scraps Hearing Loss Drug After Phase 3 Flop, Shares Routed

Health Earnings